Global Information
회사소개 | 문의 | 위시리스트

세계의 지혈제 및 조직 접합제 시장(국소 지혈제, 조직 접합제) : 업계 분석, 시장 규모, 시장 점유율, 성장률, 동향 및 향후 예측(2014-2020년)

Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

리서치사 Transparency Market Research
발행일 2015년 01월 상품 코드 326020
페이지 정보 영문 85 Pages
가격
US $ 5,795 ₩ 6,860,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 10,411,000 PDF by E-mail (5-user license) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 13,962,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 지혈제 및 조직 접합제 시장(국소 지혈제, 조직 접합제) : 업계 분석, 시장 규모, 시장 점유율, 성장률, 동향 및 향후 예측(2014-2020년) Hemostasis and Tissue Sealing Agents Market (Topical Hemostats and Tissue Sealing Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
발행일 : 2015년 01월 페이지 정보 : 영문 85 Pages

지혈제 및 조직 접합제 시장은 출혈 관리 면에서 외과수술을 뒷받침하는 지혈제, 조직 접합제, 유착 방지제에 대해 광범위한 연구를 필요로 하는 분야입니다. 수술중에 손상된 혈관의 혈류 관리에 있어서 이러한 상품들이 꼭 필요한 역할을 담당하고 있으며, 최근 첨단 기술 개발이 발전과 비용 효과에 기여하고 있습니다.

세계의 지혈제(Hemostasis) 및 조직 접합제(Tissue Sealing Agents) 시장에 초점을 맞추어 현황과 향후 전망을 고찰할 수 있도록 세계 전체 및 각 지역의 거래 규모 추이를 분석 예측했으며, 시장 성장 촉진요인 및 억제요인, 발전 기회, 산업 밸류체인, 경쟁 환경, 시장의 매력, 주요 시장 진출기업 프로파일 등의 정보를 전해드립니다.

제1장 서론

제2장 주요 요약

  • 시장 개요 : 세계의 지혈제 및 조직 접합제 시장
  • 세계의 지혈제 및 조직 접합제 시장 : 종류별(단위 : 100만 달러)
    • 비교 분석 : 세계의 조직 접합제 시장 - 지역별(매출 점유율)

제3장 시장 개요

  • 개요
  • 시장 역학
    • 시장 성장 촉진요인
      • 신제품 개발과 기술 향상
      • 높아지는 저침습 수술 지향
      • 인구고령화로 증가하는 지혈 제품이 필요한 수술
        • 세계의 연령 구성 변화
    • 시장 성장 억제요인
      • 고액의 비용과 엄격한 규제 요건
      • 합병증 위험
    • 기회
      • 기업의 고수익화를 위해 튼튼한 기반을 제공하는 신흥국가에서의 투자
      • 강력한 연구개발
  • Porter's Five Forces 분석 : 세계의 지혈제 및 조직 접합제 시장
  • 시장의 매력 분석 : 세계의 지혈제 및 조직 접합제 시장 - 지역별
  • 지혈제 및 조직 접합제 주요 기업의 세계 시장 점유율 경쟁 환경(매출 점유율)
    • 세계의 지혈제 및 조직 접합제 시장 점유율 분석 : 주요 기업별(매출 점유율)

제4장 세계의 지혈제 및 조직 접합제 시장 : 제품 종류별

  • 개요
    • 세계 시장 매출 : 제품 종류별(단위 : 100만 달러)
  • 국소 지혈용 제품
    • 세계 시장 매출 : 종류별(단위 : 100만 달러)
    • 기계적 지혈재
    • 활성 지혈제
    • 유동성 지혈제
  • 접합제 및 조직 접합제
    • 세계 시장 매출 : 종류별(단위 : 100만 달러)
    • 천연 조직 접합제
    • 합성 조직 접합제
    • 유착 방지 제품

제5장 세계의 지혈제 및 조직 접합제 시장 : 지역별

  • 개요
    • 세계 시장 매출 : 지역별(단위 : 100만 달러)
  • 북미
  • 유럽
  • 아시아태평양 지역
  • 기타 지역

제6장 제안

  • 다양한 용도에서 즉시 사용 가능한 제품 도입
  • 마케팅 캠페인에 주력
  • 적극적인 연구개발

제7장 기업 개요(기업 개요, 재무 상황 개요, 제품 포트폴리오, 사업 전략, 최근의 발전)

  • Advanced Medical Solutions Group plc
  • Baxter
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • C.R. Bard, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Pfizer, Inc.
LSH 15.03.27

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat, tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during the surgery. These products play an important role in management of bleeding within the damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing agents is witnessing positive growth due to the introduction of technology advanced and cost effective hemostat and tissue sealing products by key companies. For example, in June 2013, Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue adhesive.

The company also offers wide range of hemostasis and tissue sealant products such as RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of these products hence drive the market growth. Other factors such as aging population and rising number surgical procedures further drive the growth of the hemostasis and tissue sealing agents market globally. For example, according to the World Health Organization (WHO), the number of people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050. Aging population will boost the number of people undergoing surgical intervention which would in turn stimulate the demand of hemostat and tissue sealing agents. In addition, hemostat and tissue sealant products are still at a nascent stage in developing regions such as India and Latin America and expected to witness high growth rate in near future owing to the approval of new hemostat products by regulatory authorities. All these factors collectively fuel the revenues of hemostasis and tissue sealing agents market during the study period, hence boost market growth. However, strict regulatory policies coupled with high cost of the products will restrain the market growth worldwide.

This report encompasses a detailed study of various hemostat and tissue sealing agents. Hemostasis and tissue sealing agents market have been majorly segmented into types of products. This segment is categorized into two major type namely topical hemostats and adhesive and tissue sealant products. Topical hemostat products are further categorized into mechanical hemostat, active hemostat (i.e. thrombin based topical hemostat) and flowable hemostat (i.e. combinational topical hemostat). Hemostat products such as collagen, oxidized regenerated cellulose (ORC), gelatin and polysaccharide based topical hemostat are included under mechanical hemostat.

Adhesive and tissue sealant are classified into natural tissue sealant, synthetic tissue sealant and adhesion barrier products. Natural tissue sealant comprises fibrin sealant and others (albumin and collagen based tissue sealant). Synthetic sealant includes cyanoacrylate based tissue sealant and others (polyethylene glycol and others). The market size and forecast for each type of products has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.

Geographically, the global hemostasis and tissue sealing agents market has been segmented into four major regions namely North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above.

The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis and event impact analysis of the global hemostasis and tissue sealing agents market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the global hemostasis and tissue sealing agents market that have been profiled in the report include Johnson & Johnson Services, Inc., CryoLife, Inc., Baxter, Cohesion Technologies, C.R. Bard, Inc., Advance Medical Solution Group plc, Integra LifeScience, Pfizer, Inc. and others.

The Global Hemostasis and Tissue Sealing Agents market is segmented as follows:

Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • Topical Hemostats
    • Mechanical Hemostats
    • Collagen based Topical Hemostats
    • Oxidized Regenerated Cellulose (ORC) based Topical Hemostats
    • Gelatin based Topical Hemostats
    • Polysaccharide based Topical Hemostat
    • Active Hemostats (Thrombin-Based Topical Hemostats)
    • Flowable Hemostats (Combination Topical Hemostats)
  • Adhesive and Tissue Sealing Agents
    • Natural Tissue Sealant
    • Fibrin Sealant
    • Other Natural Sealant (Albumin and Collagen based Tissue Sealant)
    • Synthetic Tissue Sealant
    • Cynoacrylate-Based Tissue Adhesives
    • Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
    • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
      • 1.3.1.3 Assumption

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • 2.2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
    • 2.2.1 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Technology improvements coupled with new product development
      • 3.2.1.2 Rising trend of minimally invasive procedures
      • 3.2.1.3 Aging population increases the number of surgeries needing hemostat products
        • 3.2.1.3.1 Global Percentage Change in the World's Population by Age: 2010-2050
    • 3.2.2 Market Restraints
      • 3.2.2.1 High cost and strict regulatory requirement
      • 3.2.2.2 Risk of complications
    • 3.2.3 Opportunities
      • 3.2.3.1 Investing in emerging economies provides a good platform for companies to record high revenue
        • 3.2.3.1.1 Latin America Aging Population % Change as Compared to the total Latin American Population Age: 2005 - 2050
      • 3.2.3.2 Strong research and development
  • 3.3 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of substitutes
    • 3.3.4 Threat of new entrants
    • 3.3.5 Competitive rivalry
  • 3.4 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • 3.5 Market Share by Key Players of Global Hemostasis and Tissue Sealing Agents Market, 2013 (%)
    • 3.5.1 Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Key Players, 2013 (%)

Chapter 4 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products

  • 4.1 Overview
    • 4.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • 4.2 Topical Hemostats
    • 4.2.1 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.2.2 Mechanical Hemostats
      • 4.2.2.1 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.2.2.2 Collagen-based Hemostats
        • 4.2.2.2.1 Global Collagen-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.3 Oxidized Regenerated Cellulose-based (ORC) Hemostats
        • 4.2.2.3.1 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.4 Gelatin-based Hemostats
        • 4.2.2.4.1 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
      • 4.2.2.5 Polysaccharide-based Hemostats
        • 4.2.2.5.1 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.3 Active Hemostats (Thrombin-based Topical Hemostats)
      • 4.2.3.1 Global Active Hemostats Market Revenue, 2012 - 2020, (USD Million)
    • 4.2.4 Flowable Hemostats (Combination Topical Hemostats)
      • 4.2.4.1 Global Flowable Hemostats Market Revenue, 2012 - 2020, (USD Million)
  • 4.3 Adhesive and Tissue Sealing Agents
    • 4.3.1 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
    • 4.3.2 Natural Tissue Sealant
      • 4.3.2.1 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.2.2 Fibrin-based Tissue Sealant
        • 4.3.2.2.1 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.2.3 Other Natural Tissue Sealant (Albumin and Collagen based tissue Sealant)
        • 4.3.2.3.1 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.3 Synthetic Tissue Sealant
      • 4.3.3.1 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
      • 4.3.3.2 Cyanoacrylate-based Tissue Sealant
        • 4.3.3.2.1 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
      • 4.3.3.3 Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
        • 4.3.3.3.1 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020, (USD Million)
    • 4.3.4 Adhesion Barrier Products
      • 4.3.4.1 Global Adhesion Barrier Products Market Revenue, 2012 - 2020, (USD Million)

Chapter 5 Global Hemostasis and Tissue Sealing Agents Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020, (USD Million)

Chapter 6 Recommendations

  • 6.1 Market Strategy for Success
    • 6.1.1 Introduction of multi-usage and ready to use products
    • 6.1.2 Increasing emphasis on marketing campaigns
    • 6.1.3 Rigorous research and development initiatives

Chapter 7 Company Profiles

  • 7.1 Advanced Medical Solutions Group plc
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Baxter
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Cohera Medical, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 CryoLife, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 C.R. Bard, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 Johnson & Johnson Services, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Integra LifeSciences Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Development
  • 7.8 Pfizer, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments

List of Figures

  • FIG. 1 Global Hemostasis and Tissue Sealing Agents Market: Market Segmentation
  • FIG. 2 Global Hemostasis and Tissue Sealing Agents Market, by Types of Products, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2013 and 2020 (Value %)
  • FIG. 4 Global Percentage Change in the World's Population by Age: 2010-2050
  • FIG. 5 Latin America Aging Population % Change Compared to the total Latin American Population Age: 2005 - 2050
  • FIG. 6 Porter's Five Forces Analysis: Global Hemostasis and Tissue Sealing Agents Market
  • FIG. 7 Market Attractiveness Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Geography
  • FIG. 8 Global Hemostasis and Tissue Sealing Agents Market: Market Share, by Key Players, 2013 (%)
  • FIG. 9 Global Collagen-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Global ORC-based Topical Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Gelatin-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Polysaccharide-based Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Active Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Flowable Hemostats Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Fibrin-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Other Natural Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 Global Cyanoacrylate-based Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Global Other Synthetic Tissue Sealant Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Global Adhesion Barrier Products Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 North America Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Europe Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 22 Asia-Pacific Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 23 RoW Hemostasis and Tissue Sealing Agents Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 24 Advanced Medical Solutions Group plc: Annual Revenues, 2011 - 2013 (USD Million)
  • FIG. 25 Baxter, Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 26 CryoLife, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 C. R. Bard, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 28 Johnson & Johnson Services, Inc., Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 29 Integra LifeSciences Corporation, Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30 Pfizer, Inc., Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Hemostasis and Tissue Sealing Agents Market (2013 & 2020)
  • TABLE 2 Impact Analysis of Market Drivers
  • TABLE 3 Impact Analysis of Market Restraints
  • TABLE 4 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Types of Products, 2012 - 2020 (USD Million)
  • TABLE 5 Global Topical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 6 Global Mechanical Hemostats Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 7 Global Adhesive and Tissue Sealing Agents Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 8 Global Natural Tissue Sealants Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 9 Global Synthetic Tissue Sealant Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 10 Global Hemostasis and Tissue Sealing Agents Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top
전화 문의
F A Q